EUVIMEDEUVIMED entdecken
Crossref

Astragaloside II-preconditioned bone marrow mesenchymal stem cells attenuate sepsis-induced acute lung injury by restoring mitochondrial function via NRF2/PGC-1α pathway activation

Hongyu Zhang, Yan Sun, Yongjun Tang, Lidan Yao, Xiherezhati Abulimiti, Qinfen Wu

Biochemical and Biophysical Research Communications · 2026-09 · 829 · 154148

DOI: 10.1016/j.bbrc.2026.154148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Hongyu Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The Second Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, 830000, China. Electronic ad…. Hauptthemen laut MEDLINE: Acute Lung Injury, Sepsis, NF-E2-Related Factor 2, Mesenchymal Stem Cells. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Sepsis-induced acute lung injury (ALI) is characterized by mitochondrial dysfunction and oxidative stress, contributing to high mortality rates. This study investigates the protective effects of astragaloside II (ASII)-preconditioned bone marrow mesenchymal stem cells (BMSCs) on sepsis-induced ALI and explores the underlying mechanism. METHODS BMSCs were isolated from C57BL/6 mice and preconditioned with ASII. The viability, migration, and apoptosis of these BMSCs were assessed. LPS-injured MLE-12 cells were co-cultured with ASII-preconditioned BMSCs to evaluate their protective effects on cell survival, apoptosis, mitochondrial membrane potential, and oxidative stress markers. A cecal ligation and puncture (CLP)-induced sepsis model in mice was used to assess the in vivo efficacy of ASII-preconditioned BMSCs on lung injury, pulmonary edema, inflammation, and apoptosis. The involvement of the NRF2 pathway was confirmed using a specific inhibitor, ML385. RESULTS BMSCs pretreated with ASII exhibited enhanced viability, migration, and resistance to apoptosis. In LPS-injured MLE-12 cells, ASII-preconditioned BMSCs improved cell survival, reduced apoptosis, and restored mitochondrial membrane potential by modulating mitochondrial dynamics (increasing Mfn2 and decreasing Fis1 expression) and promoting mitochondrial biogenesis via the NRF2/PGC-1α/Nrf1/Tfam signaling axis. These protective effects were attenuated upon NRF2 inhibition with ML385, confirming NRF2 pathway involvement. In a CLP-induced sepsis model, ASII-preconditioned BMSCs significantly reduced lung injury, pulmonary edema, and apoptosis, while lowering inflammatory cytokine levels (TNF-α, IL-1β, IL-6) and increasing TIPE2 in bronchoalveolar lavage fluid. CONCLUSIONS Collectively, these findings highlight ASII preconditioning as an effective strategy to enhance BMSCs therapeutic efficacy for sepsis-induced ALI through NRF2-mediated mitochondrial protection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjurySepsisNF-E2-Related Factor 2Mesenchymal Stem CellsSaponinsMitochondriaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAnimalsMice, Inbred C57BLMaleSignal TransductionMiceApoptosisBone Marrow CellsLipopolysaccharidesMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

Acute lung injuryAstragaloside IIBone marrow mesenchymal stem cellsMitochondrial functionNRF2 pathwaySepsis

Substanzen

NF-E2-Related Factor 2SaponinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPpargc1a protein, mouseNfe2l2 protein, mouseLipopolysaccharides

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The Second Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, 830000, China. Electronic address: 18799133058@163.com.
  • Department of Critical Care Medicine, The Second Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, 830000, China.
  • Department of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, 830000, China. Electronic address: wqfcat@163.com.

Zitieren

APA

Zhang, H., Sun, Y., Tang, Y., Yao, L., Abulimiti, X., & Wu, Q. (2026). Astragaloside II-preconditioned bone marrow mesenchymal stem cells attenuate sepsis-induced acute lung injury by restoring mitochondrial function via NRF2/PGC-1α pathway activation. Biochemical and Biophysical Research Communications, 829, 154148. https://doi.org/10.1016/j.bbrc.2026.154148

Vancouver

Zhang H, Sun Y, Tang Y, Yao L, Abulimiti X, Wu Q. Astragaloside II-preconditioned bone marrow mesenchymal stem cells attenuate sepsis-induced acute lung injury by restoring mitochondrial function via NRF2/PGC-1α pathway activation. Biochemical and Biophysical Research Communications. 2026;829:154148. doi:10.1016/j.bbrc.2026.154148

BibTeX
@article{Zhang2026,
  author = {Zhang, Hongyu and Sun, Yan and Tang, Yongjun and Yao, Lidan and Abulimiti, Xiherezhati and Wu, Qinfen},
  title = {Astragaloside II-preconditioned bone marrow mesenchymal stem cells attenuate sepsis-induced acute lung injury by restoring mitochondrial function via NRF2/PGC-1α pathway activation},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {829},
  pages = {154148},
  doi = {10.1016/j.bbrc.2026.154148}
}
Kostenlos starten →